X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacology & pharmacy (7) 7
europe (6) 6
index medicus (5) 5
pharmacology (5) 5
drugs (4) 4
medicines (4) 4
adaptive pathways (3) 3
analysis (3) 3
european union (3) 3
health care economics and organizations (3) 3
humans (3) 3
marketing authorization (3) 3
payers (3) 3
pharmaceutical industry (3) 3
public health (3) 3
agreements (2) 2
cancer (2) 2
cancer drugs (2) 2
cost (2) 2
dabigatran (2) 2
demand-side measures (2) 2
drug approval (2) 2
drug industry - organization & administration (2) 2
economics (2) 2
ema (2) 2
enhance prescribing efficiency (2) 2
future (2) 2
health care sciences & services (2) 2
health insurance (2) 2
health policy & services (2) 2
health technology assessment (2) 2
health technology-assessment (2) 2
managed entry (2) 2
managed entry agreements (2) 2
marketing (2) 2
original research (2) 2
pharmacoeconomics (2) 2
policies (2) 2
price (2) 2
prices (2) 2
rare diseases (2) 2
access (1) 1
adolescent (1) 1
adult (1) 1
adverse drug reaction reporting systems - statistics & numerical data (1) 1
aged (1) 1
aged, 80 and over (1) 1
allied health care professionals (1) 1
anticancer drugs (1) 1
antineoplastic medicines (1) 1
antiviral agents (1) 1
atrial-fibrillation (1) 1
availability (1) 1
biological effects (1) 1
biological locomotion (1) 1
biological products (1) 1
biology and life sciences (1) 1
biosimilar pharmaceuticals (1) 1
boceprevir (1) 1
bowel disease (1) 1
cancer therapies (1) 1
care (1) 1
case-history (1) 1
chemistry (1) 1
child (1) 1
child, preschool (1) 1
chronic hepatitis-c (1) 1
commerce (1) 1
communications (1) 1
compliance (1) 1
consumers (1) 1
cost-effectiveness (1) 1
cross border agreements (1) 1
cross national drug utilisation study (1) 1
cross national drug utilization study (1) 1
databases, factual (1) 1
delivery of health care - economics (1) 1
delivery of health care - organization & administration (1) 1
demand -side measures (1) 1
dk/atira/pure/subjectarea/asjc/2700/2736 (1) 1
dk/atira/pure/subjectarea/asjc/3000/3004 (1) 1
dosage and administration (1) 1
drug approval - organization & administration (1) 1
drug dosages (1) 1
drug industry - economics (1) 1
drug industry - legislation & jurisprudence (1) 1
drug shortage (1) 1
drug shortage ; pharmaceutical policy ; health care system ; legislation ; organizational framework ; europe ; european union ; western asia (1) 1
drug stores (1) 1
drug therapy (1) 1
economic framework (1) 1
economics, pharmaceutical (1) 1
eunethta (1) 1
europe, eastern (1) 1
european countries (1) 1
european legislation (1) 1
european medicines agency (1) 1
experiences (1) 1
female (1) 1
financing (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Research in social & administrative pharmacy : RSAP, ISSN 1551-7411, 06/2019
Antineoplastic medicines affect the patients' physical and psychosocial well-being posing challenges for patients, caregivers and healthcare professionals.... 
Journal Article
International Journal of Risk and Safety in Medicine, ISSN 0924-6479, 2013, Volume 25, Issue 1, pp. 17 - 27
Journal Article
WHO Drug Information, ISSN 1010-9609, 09/2011, Volume 25, Issue 4, p. 343
Each operator will be inspected at least once every three years and more often in accordance with risk evaluation. Since publication of the Clinical Trials... 
Drugs | Laws, regulations and rules | Generic products | Compliance | Research & development--R&D | Regulation | Life sciences | Pharmaceutical industry | Public health | Marketing
Journal Article
PharmacoEconomics, ISSN 1170-7690, 12/2017, Volume 35, Issue 12, pp. 1271 - 1285
Journal Article
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 07/2016, Volume 7, p. 197
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 01/2018, Volume 8, p. 942
Drug shortages have been identified as a public health problem in an increasing number of countries. This can negatively impact on the quality and efficiency... 
Health care system | Pharmaceutical policy | European Union | Organizational framework | Europe | Legislation | Western Asia | Drug shortage | UNITED-STATES | PATIENT-CARE | drug shortage | MEDICATIONS | FUTURE | ENHANCE PRESCRIBING EFFICIENCY | POLICIES | IMPACT | pharmaceutical policy | organizational framework | DEMAND-SIDE MEASURES | PHARMACOLOGY & PHARMACY | health care system | legislation
Journal Article
Frontiers in Public Health, ISSN 2296-2565, 12/2018, Volume 6, p. 328
Journal Article
Journal Article